Last updated: 2026-09-08 09:45:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
KORU Medical Systems, Inc. (KRMD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $3.25, with a market capitalization of $150.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.14 to $6.61. This page covers its latest market performance, valuation, price trends and company information.
$150.06M | |
$3.25 | |
$12.84 | |
$1.82 | |
-- | |
-- | |
195.05K | |
-- | |
$6.61 | |
$3.14 | |
-- | |
-- |
KORU Medical Systems, Inc. (KRMD) is trading at $3.30 in pre-market trading as of 2026-09-08 08:01:00, -- from the previous close of $0.00
Pre-market trading shows how investors are pricing KRMD before the regular session opens. The current pre-market price is -- the previous close, indicating positive early trading sentiment.
Over the past seven days, KORU Medical Systems, Inc. (KRMD) moved from $3.20 to $3.25, representing a gain of 1.53% ($0.05).
The stock traded between $3.16 and $3.43 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 153.39 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 3.1%
KRMD is currently trading at $3.25, placing it 3.1% of the way from its 52-week low of $3.14 to its 52-week high of $6.61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 73 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of KORU Medical Systems, Inc. (KRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.